This event is now apart of the Genetics Week Virtual Event Series.
The 4th Annual Event in the Molecular Diagnostics Virtual Event Series is now available On Demand! The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing.
This premiere, online-only, event is free to attend and brought together the molecular diagnostics community to discuss and present the newest advances in molecular diagnostics testing.
Topic's for this years event included:
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.
Use #LRmoldx to follow the conversation!
MIT McGovern Institute Fellow
MIT McGovern Institute Fellow, Massachusetts Institute of Technology
Co-Founder, Nanosens, Assistant Professor of Biomedical Sciences at Keck Graduate Institute, Visiting Assistant Professor at UC Berkeley
Director of Clinical Operations, Microbiology Service, Associate Attending Microbiologist, Departments of Medicine and Laboratory Medicine, Memorial Sloan Kettering Cancer Center
Chief Scientific Officer, N-of-One, A QIAGEN Company
Laboratory Operations Director, Navican Precision Cancer Care
Senior Research Analyst for Medical Policy & Technology Evaluation, Independence Blue Cross
Associate Director Global Product Management NGS, QIAGEN
Senior Global Product Manager of Personalized Healthcare/Oncology at QIAGEN
Global Product Director of Oncology, QIAGEN Digital Insights
Executive Director of the Advanced Diagnostic Laboratories, Moffitt Cancer Center
Global Director of Medical Affairs, Microbiology , Roche Molecular Systems
Director, Clinical Microbiology Laboratory, Associate Director, Division of Clinical Pathology, Professor of Pathology, University of Michigan
Director, Clinical and Molecular Microbiology, Cook Children's Medical Center
Principal Genome Scientist, Bioinformatics - Genetic Disease , QIAGEN
Vice President, Biomedical Informatics, QIAGEN
Director of Medical Affairs, Point-of-Care, Roche Molecular Systems
DiaSorin Molecular LLC manufactures and distributes molecular diagnostic products worldwide. Our Simplexa® molecular kits include HSV 1 & 2, Flu A/B & RSV, COVID-19, Bordetella, VZV, Group A Strep, GBS, C. difficile and our latest: SARS-CoV-2 Variants (RUO)*. Additionally ...See more See less
Bio-Rad's Single-Cell ATAC-Seq (scATAC-Seq) enables genome-wide profiling of epigenomic landscape at the single-cell level with high number of reads per cell so you can better understand the mechanisms that drive how genes are regulated.
As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
Delivering a better way to improve patient outcomes by enabling access to molecular diagnostic testing everywhere.
THE PHARMA DATA is an Informatic Centric Website focused mainly on the Pharmaceutical Industry Online. It is a B2B Platform mainly focus on latest Pharma News, Press Release, Industry related updates, Events, and Conferences. With The Pharma Data, you can get all information that ...See more See less
We are pleased to invite the contributors across the globe on its "International Conference on Biomarkers and Clinical Research" which is slated at Abu Dhabi, UAE during July 15-16, 2019 around the theme "Awareness of Biomarkers & Clinical Research ".It covers topics such as ...See more See less
Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...See more See less
Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...See more See less
Emily Hollister is the Director, R&D, Computational Biology for Diversigen. An accomplished microbial ecologist, her microbiome experience ranges from soils and biofuel production systems to the human microbiome and pre-clinical disease models. She leads a team of ...See more See less
Dr. Christopher Mason completed his dual B.S. in Genetics and Biochemistry (2001) from University of Wisconsin-Madison, his Ph.D. in Genetics (2006) from Yale University, and then completed post-doctoral training in clinical genetics (2009) at Yale Medical School, and a joint ...See more See less
Eugean Jiwanmall's past professional experiences include basic science and clinical research. In his current role as a Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross' Claim Payment Policy Department within Facilitated Health ...See more See less
Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...See more See less